$BIIB Recent Headlines Investors gloss over Biogen

New Post Public Reply Private Reply Replies (0) Message Board

Apr 27, 2014 at 11:36 AM

$BIIB Recent Headlines

Investors gloss over Biogen earnings miss and focus on MS drug sales 2:23 p.m. April 23, 2014 - blogs.marketwatch.com
Scouring the moonscape for leading stocks 3:01 p.m. April 22, 2014 - The Trading Deck
Apple, Microsoft are not the keys to this week’s news 7:00 a.m. April 22, 2014 - Marek Fuchs
Long view on stocks is best during weak earnings season 6:00 a.m. April 20, 2014 - Wallace Witkowski
Biotech misses out on Nasdaq rally, sinks further into bear ground 4:58 p.m. April 14, 2014 - blogs.marketwatch.com
Herbalife sinks on probe fears; Zoe’s surges on debut 4:36 p.m. April 11, 2014 - Ben Eisen
Stocks fall for 3rd day in row; S&P 500 down for year again: stock market live blog recap 4:11 p.m. April 7, 2014 - blogs.marketwatch.com
Biotech bargain? 11:43 a.m. April 1, 2014 - The Trading Deck
Facebook, Biogen, Cal-Maine are stocks to watch 5:21 a.m. March 31, 2014 - Victor Reklaitis
U.S. stocks end week with losses 7:17 p.m. March 28, 2014 - Anora Mahmudova
Nasdaq pullback rife with opportunity 2:07 p.m. March 25, 2014 - The Trading Deck
Biotech comeback stalls as Wall Street starts to worry 12:45 p.m. March 25, 2014 - blogs.marketwatch.com
U.S. stocks fall; Nasdaq skids 1.2% 4:40 p.m. March 24, 2014 - Anora Mahmudova
Biotech has second straight sell-off; sector mutual funds take it on chin 10:40 a.m. March 24, 2014 - blogs.marketwatch.com
First Solar extends winning streak; Symantec plunges 3:06 p.m. March 21, 2014 - Ben Eisen
Investors let air out of biotech amid overheating, pricing concerns 1:42 p.m. March 21, 2014 - blogs.marketwatch.com
U.S. stocks rise; S&P 500 positive for the year 4:39 p.m. March 17, 2014 - Anora Mahmudova
Yahoo gains on Alibaba IPO; Plug Power loses momentum 4:17 p.m. March 17, 2014 - Saumya Vaishampayan
Keurig Green Mountain added to S&P 500 index 9:56 a.m. March 15, 2014 - MarketWatch.com
From every angle, technicals point to richer stocks 2:25 p.m. March 11, 2014 - The Trading Deck

Disappointments? Think Opportunities; Miracle Drug May Be Ailing Gilead: Jim Cramer's Best Blogs 6:00 a.m. April 26, 2014 - TheStreet.com
Amgen Blazed Biotech Trail, Earned 165,233% Reward 5:51 p.m. April 25, 2014 - Investors Business Daily
3 Stocks Reiterated As A Buy: EBAY, AXP, BIIB 3:59 p.m. April 25, 2014 - TheStreet.com
Spectrum Pharma Candidate Gets Positive Data - Analyst Blog 5:50 p.m. April 24, 2014 - Zacks.com
Gilead, Alexion, Biogen, Or Celgene: 1 Mindboggling Metric Identifies The Best Value! 4:57 p.m. April 24, 2014 - Seeking Alpha
3 Drugs Stocks Dragging The Industry Down 1:03 p.m. April 24, 2014 - TheStreet.com
Stock Market News for April 24, 2014 - Market News 10:06 a.m. April 24, 2014 - Zacks.com
Ambit Biosciences Slumps: AMBI Falls 7.1% in Session - Tale of the Tape 8:49 a.m. April 24, 2014 - Zacks.com
Prothena Corporation plc (PRTA) Worth Watching: Stock Rises 9.5% - Tale of the Tape 8:44 a.m. April 24, 2014 - Zacks.com
Biogen partners with Quintiles to beef up its clinical development processes 8:18 a.m. April 24, 2014 - Seeking Alpha
Biogen Idec Inc. (BIIB): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. April 24, 2014 - Zacks.com
Quintiles, Biogen Idec Announce Comprehensive Clinical Development Partnership 7:01 a.m. April 24, 2014 - benzinga.com
After the Apple Split, Five More Bull Market Stock Splits Needed 6:39 a.m. April 24, 2014 - 247WallSt.com
Biogen Idec's CEO Discusses Q1 2014 Earnings Results - Earnings Call Transcript 10:54 p.m. April 23, 2014 - Seeking Alpha
Will Today Be the Day the Dow Finally Does It? 9:11 p.m. April 23, 2014 - InvestorPlace.com
Biogen Q1, Guidance Strong, But Stock Slips 5:46 p.m. April 23, 2014 - Investors Business Daily
Why Biogen (BIIB) Stock Is Down Today 1:55 p.m. April 23, 2014 - TheStreet.com
Biogen's Q1 Earnings Soar Y/Y on Tecfidera Sales - Analyst Blog 1:40 p.m. April 23, 2014 - Zacks.com
10-Q: BIOGEN IDEC INC. 1:26 p.m. April 23, 2014 - Edgar Online - (EDG = 10Q, 10K)
Biogen Q1 Sales Beat Street, Guidance Strong 9:11 a.m. April 23, 2014 - Investors Business Daily

Quintiles and Biogen Idec Announce Comprehensive Clinical Development Partnership 8:01 a.m. April 24, 2014 - BusinessWire - BZX
Biogen Idec Signs License Agreement With Amunix for XTENylated Factor VIII 8:02 a.m. April 21, 2014 - Marketwire
RBCC Bioprinting Partner Expands Brand Awareness Campaign 4:28 a.m. April 16, 2014 - BusinessWire - BZX
Surveyed European Neurologists Expect to Prescribe Biogen Idec's Tecfidera to 16 Percent of their Diagnosed Relapsing-Remitting Multiple Sclerosis Patients in the Next 12 Months 1:00 p.m. April 15, 2014 - PR Newswire - PRF
Legal Updates, Stock Price Movements, New Awareness Campaigns, and Senior-level Appointments - Analyst Notes on Mylan, WellPoint, Forest, Novatis and Intercept 8:00 a.m. April 15, 2014 - PR Newswire - PRF
Biogen Idec to Present New Clinical Data from Its Robust Neurology Portfolio at AAN Annual Meeting 7:30 a.m. April 14, 2014 - BusinessWire - BZX
JPMorgan Chase First Quarter Earnings Falls 20 Percent; FBI Probes Herbalife Business 12:36 a.m. April 14, 2014 - ACCESSWIRE
Pfizer’s Ian Read Becomes PhRMA Board Chairman; Ken Frazier, George Scangos Assume New Posts 9:00 a.m. April 11, 2014 - BusinessWire - BZX
Biogen Idec Names Adam M. Koppel as SVP and Chief Strategy Officer 7:30 a.m. April 10, 2014 - BusinessWire - BZX
Biogen Idec and Sobi announce positive top-line efficacy and safety results from phase-3 paediatric study of investigational therapy Eloctate(TM) (rFVIIIFc) for haemophilia A 7:06 a.m. April 10, 2014 - Thomson Reuters ONE
Biogen Idec and Sobi Announce Positive Top-Line Efficacy and Safety Results from Phase 3 Pediatric Study of Investigational Therapy Eloctate™ (rFVIIIFc) for Hemophilia A 7:00 a.m. April 10, 2014 - BusinessWire - BZX
RBCC and n3D Seek Out Additional Capital 5:00 a.m. April 9, 2014 - BusinessWire - BZX
Earnings Release Schedules, Product Portfolio Expansion, Initiatives and Stock Price Movements - Analyst Notes on Biogen Idec, Bristol-Myers, Regeneron Pharma, Illumina, West Pharma Services 8:00 a.m. April 8, 2014 - PR Newswire - PRF
Bioprinting Investment Puts RBCC at Forefront of 3-D Revolution 5:00 a.m. April 3, 2014 - BusinessWire - BZX
Biogen Idec to Report First Quarter 2014 Financial Results on April 23, 2014 4:01 p.m. March 31, 2014 - BusinessWire - BZX
Sobi: US FDA approves Alprolix(TM) 2:05 a.m. March 31, 2014 - GlobeNewswire
Sobi: US FDA approves Alprolix(TM) 2:01 a.m. March 31, 2014 - Thomson Reuters ONE
FDA Approves Biogen Idec’s ALPROLIX™, the First Hemophilia B Therapy to Reduce Bleeding Episodes with Prophylactic Infusions Starting at Least a Week Apart 6:34 p.m. March 28, 2014 - BusinessWire - BZX
FDA Approves Biogen Idec’s ALPROLIX™, the First Hemophilia B Therapy to Reduce Bleeding Episodes with Prophylactic Infusions Starting at Least a Week Apart 6:24 p.m. March 28, 2014 - BusinessWire - BZX
Critical Alerts For DirecTV, Biogen Idec, Time Warner, Isis Pharmaceuticals, and DreamWorks Animation Released By InvestorsObserver 9:31 a.m. March 27, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PVOLVE Expands in Connecticut with Two New Studios

PVOLVE's adventure in Connecticut is heating up with a couple of fresh franchise locations. These aren't just any run-of-the-mill expansions either. They're being spearheaded by the franchise veterans and Darien studio owner Christi Partouche along with a couple of eager original members, Elizabeth and John Halvey. PVOLVE's Organic Growth in Action The Greenwich and...

Huairen Ceramics: Tech Upgrade Powers Global Aspirations

Tech Revolution in Porcelain's Traditional Hearth Imagine robots glazing porcelain and kilns all on autopilot—that's the new norm at Huairen City, Shanxi Province, home to China's formidable porcelain industry. Gone are the days when craftsmen relied solely on their keen senses to judge the right glaze and firing time. The latest technology has disrupted tradition here,...

United Community Rises in Top Banks, Celebrates 10-Year Streak

Celebrating a Decade of Employee Satisfaction Nailing that balance between growth and nurturing a quality workplace—now that's a hard row to hoe for many giants. Yet, United Community has strutted down this path for ten years straight, landing them again on American Banker's 'Best Banks to Work For' list. That kind of consistency screams commitment, don't it? But what's...

OpenAI Expands ChatGPT Ads: Aleph Partnership Key

OpenAI Teams Up with Aleph for Global Reach OpenAI's no rookie in the tech game, but its move to bolster ChatGPT's ad presence with Aleph is like adding a rocket to turbocharge its engine. With Aleph as a partner, OpenAI's not just dipping a toe in the waters of global advertising—they're diving headfirst into 44 countries. This isn't just about slapping ads on more...

Kyndryl's Sovereignty Strategy Tackles Digital Resilience

Driving Resilience Amidst Sovereignty Moves Hot off the press, Kyndryl is rolling out a beefed-up strategy to fortify operational resilience in the face of shifting digital sovereignty challenges. I’d say these guys got their fingers firmly on the geopolitical pulse, and they’re not messing around. “Maintaining critical IT operations is fundamental to business...

B2K's Comeback with ECLIPSE Breaks Records

Resurgence in the R&B World Well, if you told me B2K would make a grand return and rock the charts after 24 years, I'd have laughed. But it's happening—like a seasoned player making a comeback in overtime. The platinum-selling R&B group B2K launched a new album, 'ECLIPSE,' tied to their 'Boys 4 Life Tour.' The Innovative Marketing Strategy In a move that might just...

7-Eleven Heats Up Breakfast with Cheetos Taco

When Breakfast Gets a Fiery Makeover If you're craving breakfast with a side of heat, 7-Eleven's latest menu might just wake you up faster than a double espresso. Their newest collaboration with Cheetos Flamin' Hot is painting breakfast red at Laredo Taco Company, offering a lineup that's got tongues wagging and mouths watering. "After the response to our first Cheetos...

Lululemon Lawsuit Looms: Investors Face Key Decisions

Seems Lululemon just tripped on its yoga mat. When a company like Lululemon Athletica, Inc (NASDAQ:LULU) sees a 17.38% slide in stock, every savvy investor knows there's more beneath the surface. Squarely in the crosshairs of a securities fraud class action, the brand synonymous with upscale athleisure faces harsh scrutiny. And the deadline's ticking—even the suits know...

National Park Foundation's New Military Outreach Program

Bridging the Gap: Parks and Military Communities Fancy title, ain't it? But what truly matters here is how the National Park Foundation (NPF) is setting a new stage for the troops and their families. The spotlight isn't just on faceless numbers; it's on people—those who serve, their loved ones, and the memories they make far from battlefields. Launching this initiative...

Silicosis Crisis: Legal and Health Ramifications Loom

The Hidden Dangers of Artificial Stone Here's the grim truth. Artificial stone countertops, loved by many for their aesthetics in kitchens and bathrooms, have a dark side that’s becoming increasingly hard to ignore. Loaded with more than 90% respirable crystalline silica, these materials spew out toxic dust when cut or polished. Once that dust gets airborne, workers...